Carpenter TO - Search Results

1

Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.

Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Wooddell MM, Kawakami T, Ito T, Zhang X, Humphrey J, Insogna KL, Peacock M. Carpenter TO, et al. J Clin Invest. 2014 Apr;124(4):1587-97. doi: 10.1172/JCI72829. Epub 2014 Feb 24. J Clin Invest. 2014. PMID: 24569459 Free PMC article. Clinical Trial.

2

A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.

Sullivan W, Carpenter T, Glorieux F, Travers R, Insogna K. Sullivan W, et al. J Clin Endocrinol Metab. 1992 Sep;75(3):879-85. doi: 10.1210/jcem.75.3.1517380. J Clin Endocrinol Metab. 1992. PMID: 1517380

3

Vitamin D metabolism in chronic childhood hypoparathyroidism: evidence for a direct regulatory effect of calcium.

Carpenter TO, Insogna KL, Boulware SD, Mitnick MA. Carpenter TO, et al. J Pediatr. 1990 Feb;116(2):252-7. doi: 10.1016/s0022-3476(05)82883-5. J Pediatr. 1990. PMID: 2299496 Free article.

4

Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.

Carpenter TO, Mitnick MA, Ellison A, Smith C, Insogna KL. Carpenter TO, et al. J Clin Endocrinol Metab. 1994 Jun;78(6):1378-83. doi: 10.1210/jcem.78.6.8200940. J Clin Endocrinol Metab. 1994. PMID: 8200940

5

24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study.

Carpenter TO, Keller M, Schwartz D, Mitnick M, Smith C, Ellison A, Carey D, Comite F, Horst R, Travers R, Glorieux FH, Gundberg CM, Poole AR, Insogna KL. Carpenter TO, et al. J Clin Endocrinol Metab. 1996 Jun;81(6):2381-8. doi: 10.1210/jcem.81.6.8964881. J Clin Endocrinol Metab. 1996. PMID: 8964881 Clinical Trial.

6

Changes in bone turnover in young women consuming different levels of dietary protein.

Kerstetter JE, Mitnick ME, Gundberg CM, Caseria DM, Ellison AF, Carpenter TO, Insogna KL. Kerstetter JE, et al. Among authors: carpenter to. J Clin Endocrinol Metab. 1999 Mar;84(3):1052-5. doi: 10.1210/jcem.84.3.5552. J Clin Endocrinol Metab. 1999. PMID: 10084594

7

Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors.

Carpenter TO, Ellis BK, Insogna KL, Philbrick WM, Sterpka J, Shimkets R. Carpenter TO, et al. J Clin Endocrinol Metab. 2005 Feb;90(2):1012-20. doi: 10.1210/jc.2004-0357. Epub 2004 Nov 23. J Clin Endocrinol Metab. 2005. PMID: 15562028

8

Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice.

Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM. Liang G, et al. Among authors: carpenter to. Calcif Tissue Int. 2009 Sep;85(3):235-46. doi: 10.1007/s00223-009-9270-6. Epub 2009 Jul 17. Calcif Tissue Int. 2009. PMID: 19609735 Free PMC article.

9

Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.

Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ. Imel EA, et al. Among authors: carpenter to. J Clin Endocrinol Metab. 2010 Apr;95(4):1846-50. doi: 10.1210/jc.2009-1671. Epub 2010 Feb 15. J Clin Endocrinol Metab. 2010. PMID: 20157195 Free PMC article. Clinical Trial.

10

Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status.

Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM. Carpenter TO, et al. J Clin Endocrinol Metab. 2010 Nov;95(11):E352-7. doi: 10.1210/jc.2010-0589. Epub 2010 Aug 4. J Clin Endocrinol Metab. 2010. PMID: 20685863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page